EU-Japan Biotech & Pharma Partnering Conference 2026

16 Sept – 5 Oct 2026 | Osaka, Japan

HomeAgenda
Register
Register
Register

NaDeNo

Company (SME/startup) / 中小企業・スタートアップ

www.nadeno.com/Trondheim, Norway
43 profile visits

About

NaDeNo is a Norwegian biotech with a nanoparticle-based drug delivery technology for hard-to-deliver drugs and a lead asset for ovarian cancer. NaDeNo builds on over a decade of research as a spin-off from SINTEF, one of Europe’s leading research organizations.

The platform uses polymeric nanoparticles to encapsulate hydrophobic drugs in a patented one-step process, without chemically modifying the active ingredient. This supports scalable and sustainable manufacturing while enabling targeted delivery through surface customization. Our lead candidate, PACAB-002, is intended to eradicate peritoneal micrometastases in ovarian cancer, has recieved EMA Orpahn Drug Designation for ovarian cancer and will enter Phase 1 clinical trial in early 2027.

NaDeNo is an EIC Accelerator beneficiary, awarded €10 million in blended finance. We are part of AstraZeneca’s BioVentureHub, selected based on scientific merit and potential for synergies. Platform projects are ongoing, including feasibility of oral delivery with a big pharma partner.

Through pharma partnerships, NaDeNo aims to expand the clinical impact of hard-to-deliver drugs.

Social media

Business Domain / 分野

Pharmaceuticals / 医薬品

Disease Area / 疾患領域

Oncology / がんOthers / その他

Modalities / モダリティ

Small-molecule drug / 低分子医薬Others /その他

Technologies / 技術

Drug delivery system(DDS) / ドラッグデリバリーシステム(DDS)

Business Type / 業種

Others / その他

Additional Information

Researched company/organisation type / マッチングご希望企業・機関のタイプ

Companies and Academia etc. (Joint research and development purpose) / 企業やアカデミア等(共同での研究、開発を目的)Major pharma etc. (Out-licensing purpose) / 大手ファーマ等(アウトライセンスを目的)Startups, BioTech etc. (In-licensing or Partnership/Collaboration purpose) / 独自の技術やシーズを持つスタートアップ、バイオテック企業等(インライセンス、共同研究などを目的)Companies and Entities (Providing your services or technology to your clients) / 技術・サービス(研究、開発、製造等の提供を目的)AI-focused companies  etc. (Partnership/Collaboration about  AI solutions) / AIによるソリューションをもつ企業等(インライセンス、共同研究などを目的)

Researched disease area / マッチングご希望の疾患領域

Oncology / がんOthers /その他

Researched Modality / マッチングご希望のモダリティ

Small-molecule drug/低分子医薬Others / その他

Researched Technologies / マッチングご希望の技術

Others /その他